JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Axon Medchem

All

Home
Products
- Shop By Category
- Featured Products
- Shop By Alphabet
  - A
  - B
  - C
  - D
  - E
  - F
  - G
  - H
  - I
  - J
  - K
  - L
  - M
  - N
  - O
  - P
  - Q
  - R
  - S
  - T
  - U
  - V
  - W
  - X
  - Y
  - Z
  - #
Support
- - Customer Support
  - Customer Services
Contact
- About Axon Medchem
- Contact Us

Home
Products
Enzymes
Oxidoreductases
Dehydrogenases
GAPDH inhibitor compound F8

GAPDH inhibitor compound F8

Based on 1 reference(s) in Google Scholar 8 10 1

Axon 3612

CAS [252212-58-1]

MF C20H18N2O5
MW 366.37

Purity: 98%
Soluble in DMSO

Recently added

GAPDH inhibitor compound F8

Description

GAPDH inhibitor compound F8 is a non-cysteine-targeting covalent GAPDH inhibitor.

Keywords: GAPDH inhibitor compound F8 | Supplier | GAPDH inhibitor | CAS [252212-58-1] | Glyceraldehyde 3-phosphate | GAPDH | Inhibitor | Enzymes | Glycolysis | Glyceraldehyde-3-phosphate dehydrogenase

Y Jung et al. Discovery of Non-Cysteine-Targeting Covalent Inhibitors by Activity-Based Proteomic Screening with a Cysteine-Reactive Probe. ACS Chem Biol. 2022 Feb 18;17(2):340-347.

Cell Signaling & Oncology CNS Immunology Pain & Inflammation Aging research Infectious Disease EC 1.2.1.12

Covalent GAPDH inhibitor

Chemical name

2,5-Bis(3-(oxiran-2-ylmethoxy)phenyl)-1,3,4-oxadiazole

Parent CAS No.

[252212-58-1]

Order

Size	Unit Price	Stock
10 mg	€120.00	In Stock
50 mg	€480.00	In Stock

Need more? Bulk Inquiry

Please wait...